Cunha Thiago M, Verri Waldiceu A, Valério Daniel A, Guerrero Ana T, Nogueira Luciana G, Vieira Silvio M, Souza Danielle G, Teixeira Mauro M, Poole Stephen, Ferreira Sergio H, Cunha Fernando Q
Department of Pharmacology, Faculty of Medicine of Ribeirão Preto University of Sao Paulo, Av. Bandeirantes, 3900, 14049-900 Ribeirão Preto, SP, Brazil.
Eur J Pain. 2008 Nov;12(8):1059-68. doi: 10.1016/j.ejpain.2008.02.003. Epub 2008 Mar 26.
In the present study, we used the electronic version of the von Frey test to investigate the role of cytokines (TNF-alpha and IL-1beta) and chemokines (KC/CXCL-1) in the genesis of mechanical hypernociception during antigen-induced inflammation in mice. The nociceptive test consisted of evoking a hindpaw flexion reflex with a hand-held force transducer (electronic anesthesiometer) adapted with a 0.5 mm(2) polypropylene tip. The intraplantar administration of methylated bovine serum albumin (mBSA) in previously immunized (IM), but not in sham-immunized (SI) mice, induced mechanical hypernociception in a dose-dependent manner. Hypernociception induced by antigen was reduced in animals pretreated with IL-1ra and reparixin (a non-competitive allosteric inhibitor of CXCR2), and in TNF receptor type 1 deficient (TNFR1-/-) mice. Consistently, antigen challenge induced a time-dependent release of TNF-alpha, IL-1beta and KC/CXCL-1 in IM, but not in SI, mice. The increase in TNF-alpha levels preceded the increase in IL-1beta and KC/CXCL1. Antigen-induced release of IL-1beta and KC/CXCL1 was reduced in TNFR1-/- mice, and TNF-alpha-induced hypernociception was inhibited by IL-1ra and reparixin. Hypernociception induced by IL-1beta in immunized mice was inhibited by indomethacin, whereas KC/CXCL1-induced hypernociception was inhibited by indomethacin and guanethidine. Antigen-induced hypernociception was reduced by indomethacin and guanethidine and abolished by the two drugs combined. Together, these results suggest that inflammation associated with an adaptive immune response induces hypernociception that is mediated by an initial release of TNF-alpha, which triggers the subsequent release of IL-1beta and KC/CXCL1. The latter cytokines in turn stimulate the release of the direct-acting final mediators, prostanoids and sympathetic amines.
在本研究中,我们使用电子版的von Frey试验来研究细胞因子(肿瘤坏死因子-α和白细胞介素-1β)和趋化因子(KC/CXCL-1)在小鼠抗原诱导的炎症过程中机械性痛觉过敏发生中的作用。痛觉测试包括用一个适配有0.5 mm(2)聚丙烯尖端的手持式力传感器(电子麻醉计)诱发后爪屈曲反射。在先前免疫(IM)的小鼠而非假免疫(SI)的小鼠中,足底注射甲基化牛血清白蛋白(mBSA)以剂量依赖的方式诱导机械性痛觉过敏。用白细胞介素-1受体拮抗剂(IL-1ra)和瑞帕霉素(CXCR2的非竞争性变构抑制剂)预处理的动物以及1型肿瘤坏死因子受体缺陷(TNFR1-/-)小鼠中,抗原诱导的痛觉过敏减轻。一致地,抗原攻击在IM小鼠而非SI小鼠中诱导肿瘤坏死因子-α、白细胞介素-1β和KC/CXCL-1的时间依赖性释放。肿瘤坏死因子-α水平的升高先于白细胞介素-1β和KC/CXCL1的升高。在TNFR1-/-小鼠中,抗原诱导白细胞介素- β和KC/CXCL1的释放减少,并且白细胞介素-1ra和瑞帕霉素抑制肿瘤坏死因子-α诱导的痛觉过敏。消炎痛抑制免疫小鼠中白细胞介素-1β诱导的痛觉过敏,而消炎痛和胍乙啶抑制KC/CXCL1诱导的痛觉过敏。消炎痛和胍乙啶减轻抗原诱导的痛觉过敏,两者联合使用则消除该痛觉过敏。总之,这些结果表明与适应性免疫反应相关的炎症诱导痛觉过敏,其由肿瘤坏死因子-α的初始释放介导,肿瘤坏死因子-α继而触发白细胞介素-1β和KC/CXCL1的后续释放。后两种细胞因子反过来刺激直接作用的终末介质前列腺素和交感胺的释放。